Literature DB >> 18034425

Defective Artemis nuclease is characterized by coding joints with microhomology in long palindromic-nucleotide stretches.

Mirjam van der Burg1, Nicole S Verkaik, Alexander T den Dekker, Barbara H Barendregt, Ingrid Pico-Knijnenburg, Ilhan Tezcan, Jacques J M vanDongen, Dik C van Gent.   

Abstract

T-B-NK+ severe combined immunodeficiency (SCID) is caused by a defect in V(D)J recombination. A subset of these patients has a mutation in one of the non-homologous end joining (NHEJ) genes, most frequently the Artemis gene. Artemis is involved in opening of hairpin-sealed coding ends. The low levels of residual DH-JH junctions that could be amplified from patients' bone marrow precursor B cells showed high numbers of palindromic (P)-nucleotides. In 25% of junctions, microhomology was observed in the P-nucleotide regions, whereas this phenomenon was never observed in junctions amplified from bone marrow precursor B cells from healthy controls. We utilized this difference between Artemis-deficient cells and normal controls to develop a V(D)J recombination assay to determine hairpin-opening activity. Mutational analysis of the Artemis gene confirmed and extended the mapping of an N-terminal nuclease active site, which contains several indispensable aspartate residues. C-terminal deletion mutants did not show such severe defects in the V(D)J recombination assay using transient overexpression of (mutated) Artemis protein. However, a C-terminal deletion mutation causes T-B-NK+ SCID, indicating that the Artemis C terminus is essential for V(D)J recombination at the normal Artemis expression level. The V(D)J recombination assays used in this study contribute to the diagnostic strategy for T-B-NK+ SCID patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18034425     DOI: 10.1002/eji.200737624

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.

Authors:  Timo Volk; Ulrich Pannicke; Ismail Reisli; Alla Bulashevska; Julia Ritter; Andrea Björkman; Alejandro A Schäffer; Manfred Fliegauf; Esra H Sayar; Ulrich Salzer; Paul Fisch; Dietmar Pfeifer; Michela Di Virgilio; Hongzhi Cao; Fang Yang; Karin Zimmermann; Sevgi Keles; Zafer Caliskaner; S Ükrü Güner; Detlev Schindler; Lennart Hammarström; Marta Rizzi; Michael Hummel; Qiang Pan-Hammarström; Klaus Schwarz; Bodo Grimbacher
Journal:  Hum Mol Genet       Date:  2015-10-16       Impact factor: 6.150

2.  A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.

Authors:  Cheryl Jacobs; Ying Huang; Tehmina Masud; William Lu; Gerwin Westfield; William Giblin; JoAnn M Sekiguchi
Journal:  Hum Mol Genet       Date:  2010-12-08       Impact factor: 6.150

3.  Antigen Receptor Galaxy: A User-Friendly, Web-Based Tool for Analysis and Visualization of T and B Cell Receptor Repertoire Data.

Authors:  Hanna IJspeert; Pauline A van Schouwenburg; David van Zessen; Ingrid Pico-Knijnenburg; Andrew P Stubbs; Mirjam van der Burg
Journal:  J Immunol       Date:  2017-04-17       Impact factor: 5.422

4.  A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.

Authors:  Mirjam van der Burg; Hanna Ijspeert; Nicole S Verkaik; Tuba Turul; Wouter W Wiegant; Keiko Morotomi-Yano; Pierre-Olivier Mari; Ilhan Tezcan; David J Chen; Malgorzata Z Zdzienicka; Jacques J M van Dongen; Dik C van Gent
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

5.  Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.

Authors:  Kerstin Felgentreff; Yu Nee Lee; Francesco Frugoni; Likun Du; Mirjam van der Burg; Silvia Giliani; Ilhan Tezcan; Ismail Reisli; Ester Mejstrikova; Jean-Pierre de Villartay; Barry P Sleckman; John Manis; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2015-04-25       Impact factor: 10.793

6.  The Ku80 carboxy terminus stimulates joining and artemis-mediated processing of DNA ends.

Authors:  Eric Weterings; Nicole S Verkaik; Guido Keijzers; Bogdan I Florea; Shih-Ya Wang; Laura G Ortega; Naoya Uematsu; David J Chen; Dik C van Gent
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

7.  XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination.

Authors:  Hanna IJspeert; Jacob Rozmus; Klaus Schwarz; René L Warren; David van Zessen; Robert A Holt; Ingrid Pico-Knijnenburg; Erik Simons; Isabel Jerchel; Angela Wawer; Myriam Lorenz; Turkan Patıroğlu; Himmet Haluk Akar; Ricardo Leite; Nicole S Verkaik; Andrew P Stubbs; Dik C van Gent; Jacques J M van Dongen; Mirjam van der Burg
Journal:  Blood       Date:  2016-06-08       Impact factor: 22.113

Review 8.  Role of non-homologous end joining in V(D)J recombination.

Authors:  Shruti Malu; Vidyasagar Malshetty; Dailia Francis; Patricia Cortes
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

9.  ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2.

Authors:  Andrea Beucher; Julie Birraux; Leopoldine Tchouandong; Olivia Barton; Atsushi Shibata; Sandro Conrad; Aaron A Goodarzi; Andrea Krempler; Penny A Jeggo; Markus Löbrich
Journal:  EMBO J       Date:  2009-09-24       Impact factor: 11.598

10.  Impact of a hypomorphic Artemis disease allele on lymphocyte development, DNA end processing, and genome stability.

Authors:  Ying Huang; William Giblin; Martina Kubec; Gerwin Westfield; Jordan St Charles; Laurel Chadde; Stephanie Kraftson; JoAnn Sekiguchi
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.